C32 H35 F N8 O4
A1CSK
1-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-4-({5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl}amino)-1H-pyrazole-5-carboxamide
Description
Physiochemical properties
Bound structures
Interaction statistics
Ligand-specific databases
Synonyms
1-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-4-({5-[(2S...Show more
Formula
Standard InChI
InChI=1S/C32H35FN8O4/c1-20-17-39(25-18-45-19-25)11-12-40(20)24-8-10-29(35-15-24)38-27-16-37-41(30(27)31(34)42)23-6-3-21(...Show more
Standard InChI Key
FAXHQNYCJQXEDI-FQEVSTJZSA-N
SMILES
C[C@H]1CN(CCN1c2ccc(nc2)Nc3cnn(c3C(=O)N)c4ccc(cc4)CNC(=O)c5c...Show more
Source OpenEye
First observed in
Overall view, and highlighted
scaffolds and fragments ![help icon]()
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
Displayed: 1 / 2